Hybio Pharmaceutical Co., Ltd. (SHE:300199)
China
· Delayed Price · Currency is CNY 16.25
-0.03 (-0.18%)
Jun 27, 2025, 3:04 PM CST
Hybio Pharmaceutical Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 58.44 | 94.87 | 344.01 | 106.26 | 138.92 | 451.65 | Upgrade
|
Trading Asset Securities | 1.1 | 1.11 | - | 160.57 | 477.68 | - | Upgrade
|
Cash & Short-Term Investments | 59.54 | 95.97 | 344.01 | 266.83 | 616.6 | 451.65 | Upgrade
|
Cash Growth | 31.45% | -72.10% | 28.92% | -56.73% | 36.52% | -44.97% | Upgrade
|
Accounts Receivable | 172.68 | 99.87 | 145.42 | 318.07 | 282.64 | 332.01 | Upgrade
|
Other Receivables | 6.09 | 11.15 | 22.44 | 11.88 | 54.39 | 24.08 | Upgrade
|
Receivables | 178.78 | 111.02 | 167.87 | 329.95 | 337.03 | 356.09 | Upgrade
|
Inventory | 225.75 | 238.63 | 152.59 | 189.96 | 157.14 | 186.76 | Upgrade
|
Prepaid Expenses | - | 10.29 | 2.56 | 0.19 | - | - | Upgrade
|
Other Current Assets | 30.55 | 7.14 | 16.61 | 25.39 | 44.31 | 52.53 | Upgrade
|
Total Current Assets | 494.62 | 463.05 | 683.64 | 812.32 | 1,155 | 1,047 | Upgrade
|
Property, Plant & Equipment | 1,653 | 1,674 | 1,734 | 1,942 | 1,993 | 1,980 | Upgrade
|
Long-Term Investments | 7.64 | 89.11 | 105.85 | 131.11 | 139.74 | 301.88 | Upgrade
|
Goodwill | - | - | - | - | 0.19 | - | Upgrade
|
Other Intangible Assets | 286.49 | 293.41 | 222.5 | 265.05 | 263.56 | 317.36 | Upgrade
|
Long-Term Deferred Tax Assets | 42.99 | 43.76 | 39.55 | 38.01 | 34.07 | 37.73 | Upgrade
|
Long-Term Deferred Charges | 166.18 | 175.99 | 217.81 | 250.41 | 228.02 | 282.37 | Upgrade
|
Other Long-Term Assets | 387.04 | 268.53 | 273.73 | 172.5 | 93.2 | 53.59 | Upgrade
|
Total Assets | 3,038 | 3,008 | 3,277 | 3,611 | 3,906 | 4,020 | Upgrade
|
Accounts Payable | 231.8 | 218.26 | 108.5 | 129.05 | 90.73 | 125.48 | Upgrade
|
Accrued Expenses | 11.11 | 78.5 | 100.92 | 49.16 | 72.78 | 36.31 | Upgrade
|
Short-Term Debt | 634.62 | 638.99 | 634.21 | 320.92 | 338.23 | 583.16 | Upgrade
|
Current Portion of Long-Term Debt | 484.94 | 293.53 | 453.18 | 456.11 | 63.05 | 218.66 | Upgrade
|
Current Portion of Leases | - | 0.82 | 0.21 | 2.88 | 11.06 | - | Upgrade
|
Current Income Taxes Payable | 10.39 | 6.72 | 2.84 | - | 0.32 | 2.01 | Upgrade
|
Current Unearned Revenue | 82.88 | 130.55 | 55.33 | 62.69 | 48.79 | 74.21 | Upgrade
|
Other Current Liabilities | 136.26 | 57.17 | 68.26 | 127.14 | 118.86 | 57.18 | Upgrade
|
Total Current Liabilities | 1,592 | 1,425 | 1,423 | 1,148 | 743.82 | 1,097 | Upgrade
|
Long-Term Debt | 657.74 | 864.58 | 942.05 | 1,026 | 1,377 | 1,148 | Upgrade
|
Long-Term Unearned Revenue | 103.99 | 106.91 | 101.19 | 118.62 | 124.73 | 90.55 | Upgrade
|
Long-Term Deferred Tax Liabilities | 11.63 | 8.84 | 5.01 | 4.2 | 0.81 | 1.1 | Upgrade
|
Other Long-Term Liabilities | 6.29 | 6.29 | 22.29 | 17.06 | 12.3 | 6.26 | Upgrade
|
Total Liabilities | 2,372 | 2,411 | 2,494 | 2,314 | 2,258 | 2,342 | Upgrade
|
Common Stock | 883.24 | 883.24 | 883.24 | 916.93 | 916.93 | 916.93 | Upgrade
|
Additional Paid-In Capital | 1,448 | 1,448 | 1,463 | 1,748 | 1,700 | 1,777 | Upgrade
|
Retained Earnings | -1,724 | -1,794 | -1,627 | -1,113 | -740 | -770.81 | Upgrade
|
Treasury Stock | - | - | - | -318.66 | -318.66 | -318.66 | Upgrade
|
Comprehensive Income & Other | 41.13 | 41.22 | 39.27 | 37.5 | 26.51 | 33.02 | Upgrade
|
Total Common Equity | 648.4 | 578.63 | 758.8 | 1,271 | 1,585 | 1,638 | Upgrade
|
Minority Interest | 17.99 | 18.42 | 24.41 | 26.3 | 63.31 | 40.34 | Upgrade
|
Shareholders' Equity | 666.39 | 597.05 | 783.21 | 1,297 | 1,648 | 1,678 | Upgrade
|
Total Liabilities & Equity | 3,038 | 3,008 | 3,277 | 3,611 | 3,906 | 4,020 | Upgrade
|
Total Debt | 1,777 | 1,798 | 2,030 | 1,806 | 1,789 | 1,949 | Upgrade
|
Net Cash (Debt) | -1,718 | -1,702 | -1,686 | -1,540 | -1,173 | -1,498 | Upgrade
|
Net Cash Per Share | -1.89 | -1.96 | -1.90 | -1.74 | -1.14 | -1.62 | Upgrade
|
Filing Date Shares Outstanding | 883.24 | 883.24 | 883.24 | 883.24 | 883.24 | 883.24 | Upgrade
|
Total Common Shares Outstanding | 883.24 | 883.24 | 883.24 | 883.24 | 883.24 | 883.24 | Upgrade
|
Working Capital | -1,097 | -961.51 | -739.8 | -335.63 | 411.26 | -49.98 | Upgrade
|
Book Value Per Share | 0.73 | 0.66 | 0.86 | 1.44 | 1.79 | 1.85 | Upgrade
|
Tangible Book Value | 361.91 | 285.21 | 536.31 | 1,006 | 1,321 | 1,320 | Upgrade
|
Tangible Book Value Per Share | 0.41 | 0.32 | 0.61 | 1.14 | 1.50 | 1.49 | Upgrade
|
Buildings | - | 1,577 | 1,560 | 1,537 | 1,058 | 609.4 | Upgrade
|
Machinery | - | 896.3 | 832.92 | 774.95 | 769.85 | 648.13 | Upgrade
|
Construction In Progress | - | 37.11 | 67.32 | 153.99 | 699.74 | 1,188 | Upgrade
|
Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.